AWM
BBIO icon

Accurate Wealth Management’s BridgeBio Pharma BBIO Stock Holding History

Accurate Wealth Management’s Portfolio BBIO Stock Details BBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-58
Closed -$444 – 348
2022
Q4 		$444 Buy
+58
New +$555 ﹤0.01% 1494

Other funds holding BBIO

KKRC
Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACM
Aisling Capital Management New York $476M AUM 128.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
AIG
American International Group New York $609M AUM 23.67% 1-Year Est. Return

Accurate Wealth Management's BBIO Position: Q1 2023 in Review

Accurate Wealth Management sold out of BridgeBio Pharma (BBIO) in Q1 2023, closing a stake of 58 shares — an estimated $444 sold.

Accurate Wealth Management first reported a position in BBIO in Q4 2022 and held it in 1 quarter. The position peaked at $444 in Q4 2022. 213 funds tracked by Wall St. Rank hold BBIO as of Q1 2023.

  • Accurate Wealth Management reported no remaining BridgeBio Pharma position as of Q1 2023 after selling out during the quarter.
  • Accurate Wealth Management sold 58 BridgeBio Pharma shares in Q1 2023, an estimated $444.
  • Accurate Wealth Management first reported a position in BridgeBio Pharma in Q4 2022 and held it in 1 quarter.
  • Accurate Wealth Management's BridgeBio Pharma position peaked at $444 in Q4 2022.
  • 213 funds tracked by Wall St. Rank held BridgeBio Pharma as of Q1 2023.

Based on Accurate Wealth Management's 13F filing for Q1 2023, filed 13 Apr 2023.